Document Detail


Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis.
MedLine Citation:
PMID:  21926965     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Follicular lymphoma (FL) is the second-most common non-Hodgkin's lymphoma. The disease affects the lymph nodes, and 50% of patients present with bone marrow infiltration; however, the mechanisms involved in dissemination of the disease are not yet known. We previously reported that FL cells display an overexpression of Syk, a tyrosine kinase involved in many cellular processes including cell migration. Therefore, we sought to explore its role in the invasive process. Here, we show that FL patients display higher matrix metalloproteinase (MMP)-9 and vascular endothelial growth factor (VEGF) levels than healthy donors. Moreover, using Syk small interfering RNA and the Syk inhibitor R406, we demonstrate that, in FL cells, Syk is involved in the regulation of MMP-9 and VEGF expression, and that invasion and angiogenesis is mediated through a phosphatidylinositol-3 kinase (PI3K)-mammalian target of rapamycin module. Finally, using a FL xenograft mouse model we observe that fostamatinib (R788), inhibits MMP-9 expression and angiogenesis in vivo. Altogether, this study provides strong evidence that Syk represents an encouraging therapeutic target in FL and suggests the potential use of fostamatinib as an anti-invasive and anti-angiogenic drug.
Authors:
S Fruchon; S Kheirallah; T Al Saati; L Ysebaert; C Laurent; L Leseux; J J Fournié; G Laurent; C Bezombes
Related Documents :
21796755 - Gene expression under laser and light-emitting diodes radiation for modulation of cell ...
21606205 - Global defects in collagen secretion in a mia3/tango1 knockout mouse.
21696465 - Two autonomous structural modules in the fimbrial shaft adhesin fima mediate actinomyce...
21262445 - Angiogenesis in gestational vascular complications.
22375065 - Multiple post-translational modifications regulate e-cadherin transport during apoptosis.
8944915 - Penetrating micropores increase patency and achieve extensive endothelialization in sma...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-09-16
Journal Detail:
Title:  Leukemia     Volume:  26     ISSN:  1476-5551     ISO Abbreviation:  Leukemia     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-11     Completed Date:  2012-06-04     Revised Date:  2013-03-04    
Medline Journal Info:
Nlm Unique ID:  8704895     Medline TA:  Leukemia     Country:  England    
Other Details:
Languages:  eng     Pagination:  795-805     Citation Subset:  IM    
Affiliation:
CRCT INSERM UMR1037, CNRS ERL5294, Universite Toulouse, CHU Purpan, Toulouse, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Line, Tumor
Humans
Intracellular Signaling Peptides and Proteins / physiology*
Lymphoma, Follicular / pathology*
Matrix Metalloproteinase 9 / genetics
Mice
Neoplasm Invasiveness
Neovascularization, Pathologic / etiology*
Phosphatidylinositol 3-Kinases / physiology
Protein-Tyrosine Kinases / physiology*
Proto-Oncogene Proteins c-akt / physiology
Signal Transduction / physiology*
TOR Serine-Threonine Kinases / physiology*
Vascular Endothelial Growth Factor A / physiology
Chemical
Reg. No./Substance:
0/Intracellular Signaling Peptides and Proteins; 0/Vascular Endothelial Growth Factor A; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 2.7.1.1/MTOR protein, human; EC 2.7.1.1/TOR Serine-Threonine Kinases; EC 2.7.10.1/Protein-Tyrosine Kinases; EC 2.7.10.1/Syk kinase; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 3.4.24.35/Matrix Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferat...
Next Document:  Assembly of Saccharomyces cerevisiae 60S ribosomal subunits: role of factors required for 27S pre-rR...